If you have been reading about thymalfasin and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Last reviewed on 2026-07-31. Where a claim depends on a specific study, the study is described rather than over-claimed.
Thymosin alpha 1 was identified in 1977 as a component of thymosin fraction 5, a heterogeneous preparation used in early studies of thymic function. Investigators purified the active material and determined its amino acid sequence, which enabled chemical synthesis. Work in the following decades concentrated on T-cell maturation and immune reconstitution in animals and small human cohorts. Early preparations varied in composition, so results from that period are difficult to compare with studies using defined synthetic peptide.
Clinical research has examined the peptide in chronic hepatitis B and C, as a vaccine adjuvant, and in sepsis and oncology settings. Findings across trials are mixed; some report changes in selected immune markers, while others find no clear clinical benefit. Many studies are small and define outcomes differently, which limits comparison. Regulatory approval is confined to a few countries, and the compound is not an approved drug in the United States or most of Europe.
Overall evidence quality varies considerably. A large share of published reports come from single centers, rely on surrogate immunological markers, or lack adequate control groups. Systematic reviews have highlighted this heterogeneity as a barrier to pooling results. Open questions include which patients, if any, might benefit, what treatment duration is appropriate, and whether any effect is independent of standard care. The peptide is often described as an immune modulator rather than a therapy for one disease, which complicates confirmatory trial design.
Lyophilized thymosin alpha-1 is generally stored at or below minus twenty degrees Celsius, protected from moisture and light. Short-term handling at ambient temperature is possible for dry powder, but reconstituted solutions degrade faster and are usually kept at two to eight degrees Celsius with a defined expiry of days rather than weeks. Repeated freeze-thaw cycles should be avoided because they promote aggregation and loss of potency. Exact limits depend on the formulation and should follow the supplier's documentation.
Identity and purity are normally assessed by reversed-phase high-performance liquid chromatography, which separates the peptide from related impurities and truncation products. Mass spectrometry confirms molecular mass and detects modifications such as deamidation or oxidation. Amino acid analysis and peptide mapping provide additional sequence-level confirmation. For research material, a certificate of analysis typically reports these results together with water content and counter-ion identity, since the lyophilized powder is often supplied as an acetate or trifluoroacetate salt.
| Property | Value | Notes |
|---|---|---|
| First described | 1977 | Reported as a component of thymosin fraction 5 |
| Sequence length | 28 amino acids | N-terminal residue is acetylated |
| Net charge at neutral pH | Negative | Reflects a high proportion of acidic residues |
| Principal studied uses | Chronic hepatitis B and vaccine adjuvant | Research uses outnumber approved indications |
| Regulatory status | Approved in a limited number of countries | Not approved in the United States or most of Europe |
胸腺素α1（thymosin alpha 1，Tα1）是一种由28个氨基酸组成的酸性肽，N端被乙酰化，分子量约为3108道尔顿。该肽最早从牛胸腺组织提取物中分离，属于胸腺素组分5的一个成分。其序列在不同哺乳动物中高度保守，提示其具有基本的生物学功能。名称中的“α1”指其在电泳中的迁移位置，并非表示亚型编号。它既存在于胸腺，也存在于脾脏和淋巴结等免疫组织。
20世纪70年代，研究者从胸腺提取物中纯化出多种小肽，Tα1是其中被较早表征的一种。最初的制备依赖组织匀浆和层析步骤，产量低且成分复杂。随着固相肽合成技术成熟，实验室和工业界能够生产与天然序列一致的合成版本。合成肽的纯度可达95%以上，并可通过反相高效液相色谱和质谱进行鉴定。这一转变使研究不再依赖动物胸腺来源。
Routine handling calls for storage of the lyophilized powder at refrigerated temperatures, away from light, in a sealed container. Working solutions are often prepared in sterile water or buffer and kept cold between uses. Repeated freeze-thaw cycles are generally avoided because they can promote aggregation and loss of material. Laboratories usually record lot number, reconstitution date, and storage conditions so that any change in behavior can be traced to a specific preparation.
Reverse-phase high-performance liquid chromatography is the standard technique for assessing purity and concentration, because the peptide's hydrophobicity allows clean separation from related impurities. Mass spectrometry confirms molecular identity and detects sequence errors or truncations. Amino acid analysis and peptide mapping supply additional structural confirmation when required. Chromatographic purity values reported on certificates of analysis describe the proportion of the main peak and do not by themselves establish biological activity.
Thymosin alpha-1 is a synthetic 28-amino-acid peptide whose sequence was first identified in extracts of bovine thymus tissue during the 1970s. The chain carries an acetyl group on its N-terminal serine. Its acidic residue content is high, which produces strong water solubility and an isoelectric point well below neutrality. Material supplied for laboratory and clinical use is manufactured by solid-phase peptide synthesis rather than purified from animal tissue. Different salt forms, such as the acetate, alter the counter-ion content without changing the peptide backbone.
Whether the free 28-residue peptide circulates in human tissue remains debated. The best-documented human source is prothymosin alpha, a larger acidic protein that carries the sequence at its N-terminus. Reports of measurable peptide levels in serum and lymphoid tissue exist, yet some of that signal may come from cross-reacting fragments or from the parent protein. Most reviews therefore treat prothymosin alpha as the established human molecule and describe independent circulation of the small peptide as an unresolved question.
Immunological studies connect the peptide to multiple parts of the immune response. It has been reported to engage Toll-like receptor signaling, to promote dendritic cell maturation, and to influence the balance of T helper cell subsets. Changes in natural killer cell activity and in cytokine release appear in cell culture and animal models. These observations describe broad immunomodulatory behavior rather than a single defined receptor target, and the primary molecular interaction has not been settled.
4 RSeOH → 2 RSe(O)SeR + 2 H2O Even the very bulky 2,4,6-tri-tert-butylbenzeneselenenic acid disproportionates readily. Stable selenenic acids have been synthesized by burying the SeOH functional group within the cavity of a p-tert-butyl[calix[6]arene macrocycle]. In BmtSeOH (pictured), the Se-O bond length was found to be 1.808 Å while the O-Se-C angle was 96.90°. The compound was made by oxidation of BmtSeH; further oxidation gave BmtSeO2H. The Se-O absorbs in the IR spectrum at 680–700 cm−1. Selenenic acids are believed to be transient intermediates in a number of redox reactions involving organoselenium compounds. One notable example is the syn-elimination of selenoxides. Selenenic acids are also transient intermediates in the reduction of seleninic acids as well as the oxidation of diselenides. The reasoning for postulating selenenic acids as reactive intermediates is based in part on analogy with their more extensively studied sulfenic acid analogs.
La Resistencia (The Resistance) is a right-wing decentralized group that opposes the Castillo Administration. The group has been behind threats of harassment, verbal assaults, and physical attacks on citizens and government officials. La Resistencia has accused their opponents of being terrorists and Senderistas. Following repeated threats against the former supreme prosecutor Avelino Guillén and the journalist Jaime Chincha, the Ministry of the Interior has ordered an investigation into the alleged criminal organization. On 7 October 2021, approximately ten members of La Resistencia assaulted a car which had journalists inside. The car had stopped due to a red light, which the group took advantage of by repeatedly hitting the car's windows and insulting its passengers. The journalists managed to escape, but the car was battered. On 18 October 2021, members of La Resistencia interrupted the initial book sale of "Imagine a better Peru... and let's make it happen." by former President Francisco Sagasti and blocked the doorways as to prevent people from leaving. There were shouts against Sagasti, decrying him as a "murderer" and a "terrorist." Previously, Sagasti had gotten backlash from proponents that there was electoral fraud in the 2021 Peruvian general election, due to him repeatedly denying that fraud took place and handing the presidency to Castillo. On 8 November 2021, the Interior Ministry claimed that groups consisting of ex-military and ex-police personnel are appearing, many of whom being veterans of the war against the Shining Path.
== Research and Discoveries == Strahl is a pioneer in the field of epigenetics, with contributions to the study of Chromatin biology. As a postdoctoral fellow in C. David Allis’ laboratory, helped to establish the identity of the first lysine and arginine histone methyltransferases and how they contribute to transcriptional activation and heterochromatin formation. Some examples include the discovery of the first histone methyltransferases that target lysine 4 (Set1), lysine 9 (SUV39H1), and lysine 36 of histone H3 (Set2/SETD2) and arginine 3 of histone H4 (PRMT1). Strahl also helped to develop the first antibodies for methylated histones in the Allis laboratory. In 2000, Strahl and Allis put forward the idea of the “histone code hypothesis”, which aimed to explain how multiple histone modifications function together to control chromatin structure and function. The early years of the Strahl laboratory, research focused on the roles of histone methylation and histone ubiquitylation in gene transcription. He linked histone H2B ubiquitylation to the regulation of H3 lysine 79 methylation and in transcriptional elongation and determined how H3 lysine 36 methylation is coupled to RNA Polymerase II and repressive chromatin during transcription elongation. His group also defined the key roles of several histone chaperones (e.g., Spt6) that function in transcription In more recent years, Strahl turned his attention to how chromatin-associated proteins engage histones and their modifications.
Sources: en.wikipedia.org
Final lineup Cédric Toufouti – lead vocals, guitar (2008–2025) Julien Rour Chanut – guitar (2005–2025) Clément Hanvic – bass (2008–2025) Mehdi Birouk Thépegnier – drums (2005–2025) Former members Sid-Ahmed Azzouni – guitar (2005–2009; died 2010) Kéo Nackphouminh – lead vocals (2005–2008) Adrien Lederer – guitar (n/a–2010) Bernard Quarante – bass (2005–2008) Touring musicians Christophe Marconato – bass (2011)
Deprotonation of the ring-OH group converts kojic acid to kojate. Kojate chelates to iron(III), forming a red complex Fe(HOCH2C5OH2O2)3. This kind of reaction may be the basis of the biological function of kojic acid, that is, to solubilize ferric iron. Being a multifunctional molecule, kojic acid has diverse organic chemistry. The hydroxymethyl group gives the chloromethyl derivative upon treatment with thionyl chloride. Zinc-reduction of the chloromethyl compound gives allomaltol.
== Chemistry == Do6a is the most abundant peptide in D. occidentalis venom with an EC50 of 113 nM which is much lower than that of other peptides in the same venom (for example, Do10a has an EC50 of 75 μM). The sequence of Do6a shares similarities in both amino acid composition and length to a known endogenous pain signaling peptide; Vulnusin. Vulnusin, which is present in Drosophila larvae, signals the larvae to initiate puncture-induced rolling as a defense strategy for moving away from parasitoid wasps. Compared to Do6a, Vulnusin has a significantly lower EC50, making it more potent. Nevertheless, there are speculations that velvet ants evolved venom peptides similar to vulnusin in order to target the same ion channel complex. Despite being the most potent and concentrated peptide in red velvet ant venom, Do6a alone does not appear to give rise to any considerable nocifensive responses in mice, such as paw licking. Even when administered at concentrations up to 10,000 higher than the EC50 for larval nociceptor activation, its effects in mice remain negligible. This indicates that the mode of action underlying Do6a-induced nociception differs between mammals and insects.
Sources: en.wikipedia.org
Trials differ in patient population, dose schedule, background treatment, and the endpoints used to judge success. Many are small and single-center, so random variation can dominate the reported effects.
Authorization is limited to a small number of countries and covers specific indications such as chronic hepatitis B and vaccine adjuvant use. Availability and labelling differ by jurisdiction.
Most reviews describe it as an immunomodulatory agent with an uncertain clinical effect. They generally call for larger, better-controlled trials before firm conclusions are drawn.
Dry lyophilized powder tolerates short ambient exposure during handling and shipping. Long-term room-temperature storage is not recommended because moisture uptake and slow degradation can occur over months. Storage at minus twenty degrees Celsius is the common practice for extended periods.